Implantable cardioverter-defibrillators may benefit certain younger patients with mild–moderate heart dysfunction

A much than a decade-long aesculapian proceedings has opened the mode for perchance life-saving attraction options for patients with mild-to-moderate bosom conditions. Internationally recognized cardiac adept Flinders University Professor Joseph Selvanayagam, from Adelaide's Heart & Vascular, presented his findings astatine the European Society of Cardiology Congress (ESC 2026) successful Munich connected Friday. The breakthrough has besides been published successful JAMA.